logo
  • Home
  • News
Menu

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

Home / Stock Analysis / GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A
Article feature image

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

12 Aug Stock Analysis

YONGIN, South Korea–(BUSINESS WIRE)–GC Pharma (006280.KS) today announced the approval of GreenGene F (Beroctocog alfa)

Click here to view the original article.

Tags:
Business Wire, Global
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

09c136dd5280d8aa703739a9828dc6fa.jpeg
+

This Will Be Palantir’s Stock Price in 3 Years

23 Jul Stock Analysis
KSSChart-861a63b589ca415d8f1e0f27c0e2f135.gif
+

Watch These Kohl’s Stock Price Levels as Retailer Becomes Latest Meme Play

23 Jul Stock Analysis

recent post

  • 40680059.jpg

    From scrum to investment strategy: Lessons

    Jul 23 2025
  • 07e38ef8e2adc6a68a8273d81c0d580558bdf3f59dcbc40c349bdf521a14decf.webp

    PNC taps Coinbase to create crypto

    Jul 23 2025
  • SEC-Decrypt-gID_7.jpg

    ‘Bizarre Situation’: SEC Halts Conversion for

    Jul 23 2025
  • 1753255838_high.jpg

    Little Pepe Crypto Price Prediction: Here’s

    Jul 23 2025
  • eToro2028shutterstock29_id_431a5f10-4193-4660-a519-9114d35e60c3_size900.jpg

    eToro Launches Crypto, Index Futures in

    Jul 23 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.